Recent advances and future perspectives of triazole analogs as promising antiviral agents

Mini-Reviews in Medicinal Chemistry

Volumn 11, Issue 1, 2011, Pages 84-96

  Kharb, Rajeev ^a   Yar, Mohammad Shahar ^b   Sharma, Probodh Chander ^c  

^a Sanjivani College of Pharmaceutical Sciences   (India)

^b HAMDARD UNIVERSITY   (India)

^c KURUKSHETRA UNIVERSITY   (India)

Author keywords

1; 2; 3 triazole; 4 triazole; Antiviral activity; HAART; ribavirin

Indexed keywords

ANTIVIRUS AGENT; RIBAVIRIN; TARIBAVIRIN; TRIAZOLE DERIVATIVE;

ANTIVIRAL ACTIVITY; ARTICLE; AVIAN INFLUENZA VIRUS; DRUG EFFICACY; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; FATALITY; HANTAVIRUS; HERPES SIMPLEX VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; INFECTION PREVENTION; INFLUENZA VIRUS A H5N1; NONHUMAN; STRUCTURE ACTIVITY RELATION; VARICELLA ZOSTER VIRUS; VIRUS INHIBITION; VIRUS PLAQUE;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DRUG DISCOVERY; HUMANS; TRIAZOLES; VIRUSES;

EID: 78650902301     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955711793564051     Document Type: Article

References (58)

1. Lawrence, C.M.; Menon, S.; Eilers, B.J. Structural and functional studies of archaeal viruses. J. Biol. Chem., 2009, 284(19), 12599-12603.
2. Koonin, E.V.; Senkevich, T.G.; Dolja, V.V. The ancient virus world and evolution of cells. Biol. Direct, 2006, 1, 29.
3. Edwards, R.A.; Rohwer, F. Viral metagenomics. Nat. Rev. Microbiol., 2005, 3(6), 504-510.
4. Canchaya, C.; Fournous, G.; Chibani-Chennoufi, S.; Dillmann, M.L.; Brussow, H. Phage as agents of lateral gene transfer. Curr. Opin. Microbiol., 2003, 6(4), 417-424.
5. Breitbart, M.; Rohwer, F. Here a virus, there a virus, everywhere the same virus? Trends Microbiol., 2005, 13(6), 278-284.
6. Whitley, R.J.; Roizman, B. Herpes simplex virus infections. Lancet, 2001, 357 (9267), 1513-1518.
7. Kallings LO. The first postmodern pandemic: 25 years of HIV/AIDS. J. Intern. Med., 2008, 263(3), 218-243.
8. Murray, C.J.; Lopez, A.D.; Chin, B.; Feehan, D.; Hill, K.H. Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-1920 pandemic: a quantitative analysis. Lancet, 2006, 368(9554), 2211-2218.
9. Williams, R. Global challenges in liver disease. Hepatology, 2006, 44(3), 521-526.
10. Magden, J.; Kaariainen, L.; Ahola, T. Inhibitors of virus replication: recent developments and prospects. Appl. Microbiol. Biotechnol., 2005, 66(6), 612-621.
11. Kinchington, D. Recent advances in antiviral therapy. J. Clin. Pathol., 1999, 52(2), 89-94.
12. Brooksa, M.J.; Sasadeuszb, J.J.; Tannocka, G.A. Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline? Curr. Opin. Pulm. Med., 2004, 10(3), 197-203.
13. De Clercq, E. Molecular targets for antiviral agents. J. Pharmacol. Exp. Ther., 2001, 297(1), 1-10.
14. Barreca, M.L.; Chimirri, A.; Luca, L.D.; Monforte, A.M.; Monforte, P.; Rao, A.; Zappala, M.; Balzarini, J.; Clercq, E.D.; Pannecouque, C.; Witvrouw, M. Discovery of 2,3-diaryl-1,3- thiazolidin-4-ones as potent anti-HIV-1 agents. Bioorg. Med. Chem. Lett., 2001, 11(13), 1793-1796.
15. Sepkowitz, K.A. AIDS-the first 20 years. N. Engl. J. Med., 2001, 344(23), 1764-1772.
16. Weiss, R.A. How does HIV cause AIDS? Science, 1993, 260(5112), 1273-1279.
17. Rao, A.; Balzarini, J.; Carbone, A.; Chimirri, A.; Clercq, E.D.; Monforte, A.M.; Monforte, P.; Pannecouque, C.; Zappala, M. 2- (2,6-dihalophenyl)-3-(pyrimidin-2-yl)-1,3-thiazolidin-4-ones as non-nucleoside HIV-1 reverse transcriptase inhibitors. Antiviral Res., 2004, 63(2), 79-84.
18. Dybul, M.; Fauci, A.S.; Bartlett, J.G.; Kaplan, J.E.; Pau, A.K. Panel on clinical practices for treatment of HIV-guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Ann. Intern. Med., 2002, 137 (5 Pt 2), 381-433.
19. Havrylyuk, D.; Zimenkovsky, B.; Vasylenko, O.; Zaprutko, L.; Gzella, A.; Lesyk, R. Synthesis of novel thiazolone-based compounds containing pyrazoline moiety and evaluation of their anticancer activity. Eur. J. Med. Chem., 2009, 44(4), 1396-1404.
20. Kumar, V.; Sharma, A.; Sharma, P.C. Synthesis of some novel thiazolidinones from a long chain fatty acids as possible antiinflammatory, analgesic and hydrogen peroxide scavenging agents. J. Enzyme Inhib. Med. Chem., 2010, DOI: 10.3109/14756366.2010. 489897 (In press).
21. th ed.; Pergamon Press: Oxford, 1979, pp. 357.
22. rd ed.; Pearson Education India: Singapore, 2005, pp. 298-307.
23. th ed.; John Wiley & Sons Inc. Publication: New Jersy, 2008; pp. 103-109.
24. nd ed.; Wiley-VCH & Company: Deutschland, 2003, pp. 200-211.
25. Shahar Yar, M.; Mustaqeem Abdullah, M.; Husain, A.; Bakht, M.A.; De Clercq, E. Synthesis and evaluation of in vitro antiviral activity of 2-[3-(substituted phenyl)-4,5-dihydro-1H-5-pyrazolyl] benzofuran-3-yl chloride derivatives. J. Enzyme Inhib. Med. Chem., 2009, 24(4), 949-956.
26. Shaharyar, M.; Mustaqeem Abdullah, M.; Husain, A.; Bakht, M.A.; De Clercq, E. Synthesis and evaluation of in vitro antiviral activity of novel phenoxy acetic acid derivatives. J. Enzyme Inhib. Med. Chem., 2009, 24(3), 876-882.
27. Dabholkar, V.V.; Ansari, F.Y. Synthesis and biological studies of bis (thiadiazole/triazole) by sonication. Acta Pol. Pharm. Drug Res., 2008, 65(5), 521-526.
28. Kharb, R.; Sharma, P.C.; Shaharyar, M. Pharmacological significance of triazole scaffold. J. Enzyme Inhib. Med. Chem., 2010, [Epub ahead of print].
29. Torriani, F.J.; Rodriguez-Torres, M.; Rockstroh, J.K. Peginterferon -2a plus ribavirin for chronic hepatitis C virus infection in HIV- infected patients. N. Engl. J. Med., 2004, 351(5), 438-450.
30. Sidwell, R.W.; Bailey, K.W.; Wong, M.H.; Barnard, D.L.; Smee, D.F. In vitro and in vivo influenza virus-inhibitory effects of viramidine. Antiviral Res., 2005, 68(1), 8-13.
31. Elia, G.; Belloli, C.; Cirone, F. In vitro efficacy of ribavirin against canine distemper virus. Antiviral Res., 2008, 77(2), 108-113.
32. Robert, G. Treating HCV with ribavirin analogues and ribavirinlike molecules. J. Antimicrob. Chemother., 2006, 57(1), 8-13.
33. Sidwell, R.W.; Bailey, K.W.; Wong, M.H.; Barnard, D.L.; Smee, D.F. In vitro and in vivo influenza virus-inhibitory effects of viramidine. Antiviral Res., 2005, 68 (1), 8-13.
34. Singh R.J.; Singh, D.K. Synthesis, characterization and biological activity of some 1,2,4-triazole derivatives. E-J. Chem., 2009, 6(3), 796-800.
35. Sharma, P.C.; Sharma, O.P.; Vasudeva, N.; Mishra, D.N.; Singh, S.K. Anti-HIV substances of natural origin: An updated account. Nat. Prod. Rad., 2006, 5(1), 70-78.
36. Wang, Z.; Wu, B.; Kuhen, K.L.; Bursulaya, B.; Nguyen, T.N.; Nguyen, D.G.; He, Y. Synthesis and biological evaluations of sulfanyltriazoles as novel HIV-1 non-nucleoside reverse transcriptase inhibitors. Bioorg. Med. Chem. Lett., 2006, 16(16), 4174-4177.
37. De La Rosa, M.; Kim, H.W.; Gunic, E.; Jenket, C.; Boyle, U.; Koh, Y.H.; Korboukh, I.; Allan, M.; Zhang, W.; Chen, H.; Xu, W.; Nilar, S.; Yao, N.; Hamatake, R.; Lang, S.A.; Hong, Z.; Zhang, Z.; Girardet, J.L. Tri-substituted triazoles as potent non-nucleoside inhibitors of the HIV-1 reverse transcriptase. Bioorg. Med. Chem. Lett., 2006, 16(17), 4444-4449.
38. Himanshu; Tyagi, R.; Olsen, C.E.; Errington, W.; Parmar, V.S.; Prasad, A.K. Synthesis and antiviral activity evaluation of novel 2- phenyl-4-(D-arabino-4'-cycloaminobutyl)triazoles: acyclonucleosides containing unnatural bases. Bioorg. Med. Chem., 2002, 10(4), 963-968.
39. Vivet-Boudou, V.; Paillart, J.C.; Burger, A.; Marquet, R. In search of new inhibitors of HIV-1 replication: synthesis and study of 1-(2'- Deoxy- -D-Ribofuranosyl)-1,2,4-triazole-3-carboxamide as a selective viral mutagenic agent. Nucleosides Nucleotides Nucleic Acids, 2007, 26(6-7), 743-746.
40. Al-Soud, Y.A.; Al-Dweri, M.N.; Al-Masoudi, N.A. Synthesis, antitumor and antiviral properties of some 1,2,4-triazole derivatives. Farmaco., 2004, 59(10), 775-783.
41. Al-Soud, Y.A.; Al-Masoudi, N.A.; Loddo, R.; La Colla, P. In-vitro anti-HIV and antitumor activity of new 3,6-disubstituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazoles and thiadiazine analogues. Arch. Pharm., 2008, 341(6), 365-369.
42. Johns, B.A.; Weatherhead, J.G.; Allen, S.H.; Thompson, J.B.; Garvey, E.P.; Foster, S.A.; Jeffrey, J.L.; Miller, W.H. The use of oxadiazole and triazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 1: Establishing the pharmacophore. Bioorg. Med. Chem. Lett., 2009, 19(6), 1802-1806.
43. Abdel-Aal, M.T.; El-Sayed, W.A.; El-Kosy, S.M.; El-Ashry el, S.H. Synthesis and antiviral evaluation of novel 5-(N-arylaminomethyl-1,3,4-oxadiazol-2-yl)hydrazines and their sugars, 1,2,4-triazoles, tetrazoles and pyrazolyl derivatives. Arch. Pharm., 2008, 341(5), 307-313.
44. Jordao, A.K.; Afonso, P.P.; Ferreira, V.F.; De Souza, M.C.; Almeida, M.C.; Beltrame, C.O.; Paiva, D.P.; Wardell, S.M.; Wardell, J.L.; Tiekink, E.R.; Damaso, C.R.; Cunha, A.C. Antiviral evaluation of N-amino-1,2,3-triazoles against Cantagalo virus replication in cell culture. Eur. J. Med. Chem., 2009, 44(9), 3777-3783.
45. Wan, J.; Xia, Y.; Liu, Y.; Wang, M.; Rocchi, P.; Yao, J.; Qu, F.; Neyts, J.; Iovanna, J.L.; Peng, L. Discovery of novel arylethynyltriazole ribonucleosides with selective and effective antiviral and antiproliferative activity. J. Med. Chem., 2009, 52(4), 1144-1155.
46. Zhu, R.; Wang, M.; Xia, Y.; Qu, F.; Neyts, J.; Peng, L. Arylethynyltriazole acyclonucleosides inhibit hepatitis C virus replication. Bioorg. Med. Chem. Lett., 2008, 18(11), 3321-3327.
47. Shamroukh, A.H.; Ali, M.A. Anti-HAV activity of some newly synthesized triazolo[4,3-b]pyridazines. Arch. Pharm., 2008, 341(4), 223-230.
48. Zhang, Y.; Jamaluddin, M.; Wang, S.; Tian, B.; Garofalo, R.P.; Casola, A.; Brasier, A.R. Ribavirin treatment up-regulates antiviral gene expression via the interferon-stimulated response element in respiratory syncytial virus-infected epithelial cells. J. Virol., 2003, 77(10), 5933-5947.
49. Chittepu, P.; Sirivolu, V.R.; Seela, F. Nucleosides and oligonucleotides containing 1,2,3-triazole residues with nucleobase tethers: synthesis via the azide-alkyne click reaction. Bioorg. Med. Chem., 2008, 16(18), 8427-8439.
50. Chung, D.H.; Kumarapperuma, S.C.; Sun, Y.; Li, Q.; Chu, Y.K.; Arterburn, J.B.; Parker, W.B.; Smith, J.; Spik, K.; Ramanathan, H.N.; Schmaljohn, C.S.; Jonsson, C.B. Synthesis of 1- -D- ribofuranosyl-3-ethynyl-[1,2,4]triazole and its in vitro and in vivo efficacy against Hantavirus. Antiviral Res., 2008, 79(1), 19-27.
51. Li, J.; Zheng, M.; Tang, W.; He, P.L.; Zhu, W.; Li, T.; Zuo, J.P.; Liu, H.; Jiang, H. Synthesis of triazole-modified zanamivir analogues via click chemistry and anti-AIV activities. Bioorg. Med. Chem. Lett., 2006, 16(19), 5009-5013.
52. Kucukguzel, I.; Tatar, E.; Kucukguzel, S.G.; Rollas, S.; De Clercq, E. Synthesis of some novel thiourea derivatives obtained from 5- [(4-aminophenoxy)methyl]-4-alkyl/aryl-2,4-dihydro-3H-1,2,4- triazole-3-thiones and evaluation as antiviral/anti-HIV and antituberculosis agents. Eur. J. Med. Chem., 2008, 43(2), 381-392.
53. Kumarapperuma, S.C.; Sun, Y.; Jeselnik, M.; Chung, K.; Parker, W.B.; Jonsson, C.B.; Arterburn, J.B. Structural effects on the phosphorylation of 3-substituted-1--D-ribofuranosyl-1,2,4-triazoles by human adenosine kinase. Bioorg. Med. Chem. Lett., 2007, 17(11), 3203-3207.
54. Da Silva, F.D.C.; De Souza, M.C.B.V.; Frugulhetti, I.I.P.; Castro, H.C.; De Souza, O.S.L.; De Souza, T.M.L.; Rodrigues, D.Q.; Souza, A.M.T.; Abreu, P.A.; Passamani, F.; Rodrigues, C.R.; Ferreira, V.F. Synthesis Synthesis, HIV-RT inhibitory activity and SAR of 1- benzyl-1H-1,2,3-triazole derivatives of carbohydrates. Eur. J. Med. Chem., 2009, 44, 373-383.
55. Heaslet, H.; Kutilek, V.; Morris, G.M.; Lin, Y.C.; Elder, J.H.; Torbett, B.E.; Stout, C.D. Structural insights into the mechanisms of drug resistance in HIV-1 protease NL4-3. J. Mol. Biol., 2006, 356, 967-981.
56. Giffin, M.J.; Heaslet, H.; Brik, A.; Lin, Y.C.; Cauvi, G.; Wong, C.H.; McRee, D.E.; Elder, J.H.; Stout, C.D.; Torbett, B.E. A copper (I)-catalyzed 1,2,3-triazole azide-alkyne click compound is a potent inhibitor of a multidrug-resistant HIV-1 protease variant. J. Med. Chem., 2008, 51, 6263-6270.
57. Kirschberg, T.A.; Balakrishnan, M.; Huang, W.; Hluhanich, R.; Kutty, N.; Liclican, A.C.; McColl, D.J.; Squires, N.H.; Lansdon, E.B. Triazole derivatives as non nucleoside inhibitors of HIV-1 reverse transcriptase-Structure activity relationships and crystallographic analysis. Bioorg. Med. Chem. Lett., 2008, 18, 1131-1134.
58. Perez-Castro, I.; Caamano, O.; Fernandez, F.; Garcia, M.D.; Lopez, C.; De Clercq, E. Synthesis of 4-substituted-1,2,3-triazole carbanucleoside analogues of ribavirin via click chemistry. Org. Biomol. Chem., 2007, 5, 3805-3813.